RightEye’s Parkinson’s test just took a big step forward. Now it's eyeing a $15M funding round.
December 03, 2019 at 00:00 AM EST
The next round of funding would help take the Bethesda company “from adolescence to adulthood,” said co-founder and CEO Adam Gross.